In our latest episode with the discuss the promising results of a Phase I clinical trial looking at kamuvidine 8 an inflammasome inhibitor in the treatment of geographic atrophy with Dr. Jayakrishna Ambati, Guerry Professor of Ophthalmology at the University of Virginia School of Medicine.
